H&P Podium 2024
In their panel discussion, Dr Luca Santarelli, Daniel Geiger and moderator Dani von Wattenwyl gave a glimpse into the everyday life of a listed biotech company and reported first-hand on opportunities, successes and challenges. Many thanks to the speakers and all the...
Solar Power Taxation – Not Just Sunshine
Since the accelerated development of renewable energies, solar power systems haveincreasingly come into public focus—not only as a contribution to the energytransition but also as a fiscal phenomenon. With the rise of solar installations inSwitzerland, the need to...
H&P Customer Event, May 28, 2024
We are delighted to welcome our guests and two distinguished speakers at the Mövenpick Hotel in Basel on May 28. Dr Luca Santarelli and Daniel Geiger will give a personal insight into the everyday life of a listed biotech company, along with first-hand insights...
Swiss Biotech Day 2024
It was a wonderful opportunity to meet and exchange ideas with so many inspiring people dedicated to life sciences and biotech at the Swiss Biotech Day in Basel. Take a look at the video interview to hear more about an aspect of our innovative solutions and...
M&A in Health Care industry within DACH region
Within the DACH region, the number of transactions in the Health Care industry declined by 24% between 2022 and 2023. Switzerland, however, keeps developing positively and remains on a constant level when it comes to the number of transactions. In the following...
Unleash the Power of Interim Dividends: Flexibility and Dynamism in Corporate Law!
The revision of corporate law has ushered in a new era of flexibility for companies with the introduction of interim dividends. By directly distributing from the profit of the current fiscal year, companies can react more dynamically to current developments and...
Shaping Financial Services for Life Sciences Startups
Switzerland’s rise as the hub for life sciences startups is intrinsically linked to its growing ecosystem of biotech, medtech, and nanotech companies. This thriving ecosystem benefits from substantial investment in research and...
Challenging Second Half of 2023 for Swiss Start-Ups Confirms Projections
The second half of 2023 has witnessed a significant downturn in financing rounds (–34%) and funding volume (–10%) for Swiss start-ups compared to the previous year, according to the EY Startup Barometer Switzerland. This trend was anticipated in the market, and...
Have you already thought about drawing your pension?
Find out with us about the latest changes to the AHV 21 reform and how they could shape your financial future.
Hoffmann & Partner @Swiss Biotech Day
We will be at the Swiss Biotech Day 2024 in Basel on April 22-23, 2024. We are looking forward to meeting you at our booth #56.